Robuta

https://www.mdcalc.com/guidelines/10254/other/adjuvant-endocrine-therapy-women-hormone-receptor-positive-breast-cancer
ASCO 2018 guideline summary for the treatment of women with hormone receptor-positive breast cancer.
hormone receptor positiveendocrine therapyadjuvantwomenbreast
https://www.thestandard.com.hk/health-and-wellness/article/308949/Following-treatment-for-early-stage-breast-cancer-adjuvant-therapy-is-still-necessary
Breast cancer has the highest incidence among all female cancers in Hong Kong, and approximately two-thirds of patients are of the HR+/HER2- type. A study from...
early stagebreast canceradjuvant therapyfollowingtreatment
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-neratinib-extended-adjuvant-treatment-early-stage-her2-positive-breast-cancer
adjuvant treatmentearly stagefdaneratinibextended
https://www.aafp.org/pubs/afp/issues/2001/0501/p1857.html
The National Institutes of Health (NIH) has released a statement on adjuvant therapy for breast cancer. Adjuvant therapies administered after surgery eradicate...
adjuvant therapybreast cancernihstatementaafp
https://pubmed.ncbi.nlm.nih.gov/26837239/
We observed an acceptable rate of fertility preservation. Age at diagnosis influences fertility preservation.
ovarian failureimpactagecytotoxicinduced
https://pubmed.ncbi.nlm.nih.gov/26720025/
clinicaltrials.gov Identifier:NCT00311636.
adjuvant breast cancerovarian suppressiontriptorelinchemotherapy